CPHI to Hold Second Quarter 2018 Earnings Conference Call on Wednesday August 15, 2018 at 8:30 a.m. ET

HAIKOU,China,Aug. 6,2018 -- China Pharma Holdings,Inc. ("China Pharma") (NYSE MKT: CPHI),an NYSE MKT listed corporation with itsfully-integrated specialty pharmaceuticals subsidiary based in China,today announced that it plans to hold its second quarter 2018 earnings conference call on Wednesday,August 15,2018 at 8:30 a.m. ET.

Listeners may access the call by dialing 1-866-519-4004 or 65-671-350-90 for international callers,Conference ID # 6869537. A replay of the call will be accessible through August 23,2018 by dialing 1-855-452-5696 or 61-281-990-299 for international callers,Conference ID # 6869537.

About China Pharma Holdings,Inc.

China Pharma Holdings,Inc. is a specialty pharmaceutical company that develops,manufactures and markets a diversified portfolio of products focused on conditions with a high incidence and high mortality rates in China,including cardiovascular,CNS,infectious,and digestive diseases. The Company's cost-effective business model is driven by market demand and supported by new GMP-certified product lines covering the major dosage forms. In addition,the Company has a broad and expanding nationwide distribution network across all major cities and provinces in China. The Company's wholly-owned subsidiary,Hainan Helpson Medical & Biotechnology Co.,Ltd.,is located in Haikou City,Hainan Province. For more information about China Pharma Holdings,Inc.,please visit http://www.chinapharmaholdings.com. The Company routinely posts important information on its website.

Contact:

China Pharma Holdings,Inc.

Ms. Diana Na Huang

Phone: +86-898-6681-1730 (China)

Email: hps@chinapharmaholdings.com

View original content:/news-releases/cphi-to-hold-second-quarter-2018-earnings-conference-call-on-wednesday-august-15-2018-at-830-am-et-300692284.html